Stevanato Group S.p.A (STVN) FCF Margin (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly FCF Margin came in at 29.65% in Q2 2026, down 696.0% year-over-year from 4.98% in Q2 2025, and down 42.77% quarter-over-quarter from 51.81% in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) FCF Margin (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported FCF Margin for 7 consecutive years, with 29.65% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin fell 696.0% year-over-year to 29.65% in Q2 2026; TTM through Jun 2026 was 41.49%, a 89.0% increase from a year earlier, with the FY2025 full-year figure at 46.35%, up 483.0% from the prior year.
- FCF Margin was 29.65% for Q2 2026 at Stevanato Group S.p.A, down from 51.81% in the prior quarter.
- Over five years, FCF Margin peaked at 72.94% in Q1 2024 and troughed at 14.92% in Q3 2022.
- A 5-year average of 43.27% and a median of 41.88% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 4580 bps in 2023 and sank 3813 bps in 2024, its largest moves.
- Over 5 years, FCF Margin stood at 43.68% in 2022, then slumped by 34 bps to 28.76% in 2023, then soared by 39 bps to 40.08% in 2024, then jumped by 32 bps to 52.93% in 2025, then plunged by 44 bps to 29.65% in 2026.
- The last three FCF Margin figures came in at 29.65% (Q2 2026), 51.81% (Q1 2026), and 52.93% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 12.70% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 7.86% |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 9.26% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 6.11% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 29.65% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 19.22% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 8.41% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | -24.47% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.65% |
| Mar 31, 2026 | 51.81% |
| Dec 31, 2025 | 52.93% |
| Sep 30, 2025 | 30.88% |
| Jun 30, 2025 | 36.61% |
| Mar 31, 2025 | 66.34% |
| Dec 31, 2024 | 40.08% |
| Sep 30, 2024 | 22.59% |
| Jun 30, 2024 | 35.06% |
| Mar 31, 2024 | 72.94% |
| Dec 31, 2023 | 28.76% |
| Sep 30, 2023 | 60.72% |
| Jun 30, 2023 | 45.67% |
| Mar 31, 2023 | 69.27% |
| Dec 31, 2022 | 43.68% |
| Sep 30, 2022 | 14.92% |
| Jun 30, 2022 | 49.61% |
| Mar 31, 2022 | 27.30% |
| Dec 31, 2021 | 39.42% |
| Sep 30, 2021 | 21.07% |